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1. Introduction
  Lung cancer is a common malignant tumor with a high 
mortality. Searching for an effective diagnosis and treatment 
method of lung cancer is of great clinical significance[1]. 
There is evidence that microRNA (miRNA) shows significant 
effect on tumor cell proliferation and invasive metastasis[2]. 
In this study, we transiently transfected lung cancer cell line 
95-C with miRNA-10b eukaryotic expression plasmid using 
liposome technology and investigated the effects of miRNA-
10b on human lung cancer cell line 95-C proliferation and 
invasive metastasis and the underlying mechanism.
2. Materials and methods
2.1. Cell lines and reagents
  Lowly metastatic human lung cancer cell line 95-C was 
selected. The following reagents were used: RPMI 1640 
culture medium; fetal bovine serum (FBS); miRNA-10b 
eukaryotic expression plasmid; liposomal transfection 
reagents Lipofectamine®2000 and TRIzol; Transwell 
chamber; Krüppel-like factor 4 (KLF4) antibody; 
SYBRGreen PCR reagent kit; Cell Counting Kit-8 (CCK-8); 
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH).   
2.2. Cell culture
  Lowly metastatic human lung cancer cell line 95-C was 
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; 
high glucose) containing 10% FBS at room temperature in a 
5% CO2 incubator. 
2.3. Cell transfection
  Cells in the logarithmic phase were transfected as follows. 
Cells incubated in the 6-well plate were divided into three 
groups: blank control, negative control and miRNA-10b 
transfection group. Cells in the blank control group were not 
subjected to cell transfection. Cells in the negative control 
group were transfected with empty plasmid (NC sequence: 
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TTC TCC GAA CGT GTC ACG T). Cells in the miRNA-
10b group were transiently transfected with miRNA-
10b eukaryotic expression plasmid using Lipofectamine® 
2000 Transfection Reagent (Invitrogen Life Technologies, 
Carlsbad, CA, USA).
  Precisely, at 1 d prior to cell transfection, cells were 
inoculated at a density of 30%-50% overnight. Culture 
medium one was prepared by fully mixing 250 毺L Eagle’s 
minimal essential medium and 5 毺L lipofectamine® 2000 
Transfection Reagent and placing the mixture at room 
temperature for 5 min. Culture medium two was prepared 
by fully mixing 250 毺L opti-MEM and 5 毺L siRNA and 
leaving the mixture at room temperature for 20 min. After 
getting rid of culture medium, cells were cultured with 
serum- and antibiotics-free culture medium and then 
transfected with 500 毺L of liposome and siRNA solution in 
a 37 ℃ and 5% CO2 environment. After 4-6 h transfection, 
the culture medium was replaced with PBS containing 10% 
FBS. After 24 h transfection, the transfection efficacy was 
observed through the use of fluorescence microscope. 
2.4. Real time quantitative RT-PCR analysis
  After 48 h transfection, three groups of cells were collected 
and total RNA was extracted according to instruction 
provided by Taqman microRNA Reverse Transcription 
Kit and quantified by spectrophotometry. After reverse 
transcription, cDNA was synthesized from an RNA template. 
Then miRNA-10b level in the sample was detected by 
SYBRGreen quantitative PCR technique. The specific 
primers used in detection of miRNA-10b level were as 
follows: miRNA-10b upstream primer: 5’GGA TAC CCT 
GTA GAA CCG AA3’, downstream primer: 5’CAG TGC GTG 
TCG TGG AGT 3’; internal reference U6 upstream primer: 
5’TGG GGT TAT ACA TTG TGA GAG GA3’, downstream 
primer: 5’GTG TGC TAC GGA GTT CAG AGG TT3’; KLF-
4mRNA upstream primer: 5’AAG AAT CCA AAC CCA AGC3’, 
downstream primer: 5’CGA ATT TCC AGC CAC ATC3’; 
internal reference GAPDH upstream primer: 5’TCT GAT 
TTG GTC GTA TTG GG3’, downstream primer: 5’GGA AGA 
TGG TGA TGG GAT T3’. RT-PCR was performed at 95    ℃ for 
predenaturation for 10 min, followed by 40 cycles of 95  ℃ for 
15 s and 60    ℃ for 45 s. The Ct value of each sample, GAPDH 
and internal reference U6 was obtained. Then the relative 
level of miRNA-10b and KLF-4mRNA was calculated. Each 
experiment was repeated for 3 times. 
2.5. Detection of cell proliferation
  After digested with trypsin, each group of cells were diluted 
into 1-5 ×104 cells/mL. A 100 毺L aliquot of cells from each 
group were cultured in a 96-well plate and divided into 
an experimental group and a control group. Each kind of 
cells were inoculated into 3 parallel wells, 1-5×103 cells per 
well. A 100 毺L culture medium was designed as a control 
group. All cells were cultured at 37 ℃ overnight. CCK-8 and 
serum-free DMEM were fully mixed at a proportion of 1:10 
and then added to the tested wells, 100 毺L per well. Then 
cells were incubated in a 37 ℃ 5% CO2 environment for
1 h. Absorbance at 450 nm was determined and cell growth 
curves were plotted. 
2.6. Transwell invasion assays
  At 24 h prior to Transwell invasion assay, culture medium 
in each group was replaced with serum-free DMEM culture 
medium. Before cell inoculation, 24-well plates and 
Transwell chambers were soaked with PBS. Cells in each 
group were digested with trypsin, washed with serum-free 
DMEM, and then prepared into cell suspension with 1% FBS-
containing DMEM. Subsequently, cells were inoculated into 
PBS-soaked Transwell chambers at a density of 1×105 cells/
mL, 0.5 mL per chamber. 0.75 mL DMEM culture medium 
containing 10% FBS was added to the 24-well plate in the 
bottom chamber. Three parallel wells were designated for 
each group. Then the cells were incubated at 37  ℃ for 48 h. 
After addition of 1 mL of 4% formaldehyde solution into each 
well, cells were incubated at room temperature for 10 min. 
After getting rid of fixing solution, cells were washed once 
with PBS, stained with 0.5% crystal violet solution, 1 mL 
per well, for 30 min, washed three times with PBS, and then 
dried in the air. The non-migrating cells in the chamber 
were removed through the use of cotton buds. Finally, the 
cells in the field of view were observed and counted under 
200×magnification. 
2.7. Statistical analysis
  All data were statistically processed using SPSS15.0 
software. Measurement data were compared between groups 
using t test and expressed as mean 依 SD. Numeration data 
were compared between groups using chi-square test. A 
level of P<0.05 was considered statistically significant. 
3. Results 
3.1. miRNA-10b expression in transfected cells
  After 48 h transfection, the mean RQ value of miRNA-
10b in each group was determined by real time quantitative 
PCR. Compared with blank control and negative control 
groups, miRNA-10b expression was significantly increased 
in the miRNA-10b transfection group (P<0.05). There was 
no significant difference in miRNA-10b expression between 
blank control group and negative control group (P>0.05; 
Figure 1). 
3.2. Cell proliferation after transfection
  Through cell growth curves, the rate of cell growth in the 
miRNA-10b transfection group was significantly higher than 
in the blank control and negative control groups (P<0.05; 
Figure 2). 
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3.3. Transwell invasion assay results
  A significantly higher number of cells migrating through 
the Transwell membrane in the miRNA-10b transfection 
group than in the blank control and negative control 
groups (P<0.05), and there was no significant difference 
between blank control and negative control groups (P>0.05). 
This suggests that the invasive capability of miRNA-10b 
eukaryotic expression plasmid-transfected 95-C cells was 
increased (Figure 3). 
3.4. Intracellular KLF4 protein expression after transfection
  After 48 h transfection, intracellular KLF4 protein 
expression was detected by western blot analysis. 
Intracellular KLF4 protein expression in the miRNA-10b 
transfection group (0.861依0.057) was significantly lower 
than in the blank control and negative control groups 
(1.477依0.048, 1.541依0.078; P<0.05), however, there was no 
significant difference between blank control and negative 
control groups (P>0.05; Figure 4). 
3.5. Intracellular KLF4 mRNA expression after transfection 
  After 48 h transfection, the mean RQ value of miRNA-
10b in each group was determined by real time quantitative 
PCR. Intracellular KLF4 mRNA expression in the miRNA-
10b transfection group was slightly decreased than in the 
blank control and negative control groups, but there was no 
significant difference between three groups (P>0.05; Figure 
5).
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Figure 1. RT-PCR analysis of miRNA-10b expression after 
transfection.
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Figure 2. The effects of miRNA-10b on proliferation of 95-C cells.
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Figure 3. Invasive ability of 95-C over expressed MiRNA-10b 
determined by Transwell (200×).
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Figure 4. The expression of KLF4 protein in each group after 
transfection.
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Figure 5. RT-PCR analysis of KLF-4mRNA expression in 
each group after transfection.
4. Discussion
4.1. Lung cancer
  Lung cancer is highly malignant and has a high morbidity 
and mortality in China. At present, surgical removal is most 
commonly used to treat lung cancer in the clinic, because 
which can remarkably prolong patient’s survival. But most 
patients have developed advanced lung cancer at admission, 
so the treatment efficacy is not satisfactory. Therefore, 
searching for an effective diagnosis and treatment method is 
of important clinical significance[3]. 
4.2. miRNAs
  miRNAs are a class of small, non-coding single-strand 
RNA molecules[4]. miRNA is encoded by endogenous 
gene and consists of around 22 nucleotides. It has been 
documented that more than half of miRNAs are located in 
tumor-related genomic regions, fragile sites, and the regions 
of loss of heterozygosity and amplification[5]. This suggests 
that miRNA likely exhibits cancer-inhibitory effects. 
Qiao-Li Su et al./Asian Pacific Journal of Tropical Medicine (2014)364-367 367
miRNA-10b, located on Hox gene clusters, can maintain 
the proliferation of normal tissue and produce great effects 
on the proliferation and invasive metastasis of diverse 
malignant tumor cells[6]. Results from this study showed 
that 95-C cells expressing miRNA-10b were created by 
transfecting miRNA-10b plasmid into 95-C cells. Through 
cell proliferation tests, the cells with increased miRNA-
10b expression proliferated fast. Through Transwell invasion 
assay, after miRNA-10b plasmid transfection, the invasive 
capacity of 95-C cells was increased. This result suggests 
that MiRNA-10b overexpression can increase the invasive 
capacity of 95-C cells. 
4.3. miRNA-10b and lung cancer cells
  The matching degree of miRNA and its target site will 
produce great influence on miRNA functions[7,8]. If the 
matching between miRNA and the miRNA3’UTR or coding 
region of target gene is not complete, then miRNA translation 
will be inhibited, which further influences protein 
expression; complete complementary pairing will lead to the 
degradation of target gene[9-11]. A previous study reported 
that in esophageal cancer, the mRNA of KLF4 gene is a 
direct and functional target of miRNA-10b and miRNA-10b 
promotes esophageal cancer cell invasion and metastasis 
by downregulating target gene KLF4 expression[12]. KLF4 is 
a gut-enriched Krüppel-like factor 4 or an epithelial zinc 
finger-type transcription factor, belongs to the KLF family 
and is highly expressed in the digestive tract and epithelial 
cells, but its expression is downregulated in various tumor 
types[13,14]. KLF4 gene transfection can inhibit tumor cell 
growth and invasive metastasis in vivo, which occurs 
possibly due to G1/S cell cycle arrest through inhibiting 
the expression of extracellular matrix protein, cysteine-
rich acidic matrix-associated protein, upregulating p21 
expression or downregulating cyclin D1 expression. In this 
study, at 48 h after miRNA-10b transfection, KLF4 protein 
level in the cells overexpressing miRNA-10b was decreased 
as shown by western blot analysis and KLF4 mRNA 
expression in the cells overexpressing miRNA-10b was also 
decreased (taking GAPDH mRNA as an internal reference), 
as shown by real time quantitative PCR detection. But there 
were no significant differences in KLF4 mRNA expression 
between three groups. These findings suggest that miRNA-
10b exerts post-transcriptional inhibition of KLF4 mRNA 
expression. 
  A single miRNA can target multiple genes. miRNA-10b 
possibly exerts its regulatory role through the synergistic 
effects of its multiple target genes[3]. The biological functions 
of miRNA-10b in tumor cells are attributable to a series of 
related target genes. KLF4 plays an important role in lung 
cancer cell proliferation and invasive metastasis. Results 
from this study showed that KLF4 is a functional target gene 
of miRNA-10b. Whether KLF4 is a direct target gene of 
miRNA-10b remains uncertain because no corresponding 
luciferase reporter system was established, which needs to 
be further investigated in future studies.
  Taken together, results from this study showed that 
miRNA-10b can promote 95-C cell proliferation and 
invasive metastasis possibly through downregulating KLF4 
protein expression. miRNA-10b is likely to become a 
potential target for treatment of non-small cell lung cancer. 
Silencing miRNA-10b gene expression holds great promise 
for improving the prognosis of patients with non-small cell 
lung cancer. 
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